🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals injecting products of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at residence.

Within moments of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these groups, messages show dark colored packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to possibly significant health risks”.